Vanguard Group Inc Vyant Bio, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.99 - $1.61 $92,650 - $150,673	-93,586 Reduced 11.01%	756,799 $1.08 Million
Q4 2021 Feb 14, 2022	SELL	$1.32 - $2.96 $1,481 - $3,321	-1,122 Reduced 0.13%	850,385 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$2.26 - $3.74 $27,755 - $45,930	12,281 Added 1.46%	851,507 $1.98 Million
Q2 2021 Aug 13, 2021	BUY	$2.88 - $4.81 $2.42 Million - $4.04 Million	839,226 New	839,226 $3.14 Million

213K

Ticker VYNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,343,200
Description
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule c...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.